Vancomycin with concomitant piperacillin/Tazobactam vs. Cefepime or Meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study

Autor:	Buckley, Mitchell S., Komerdelj, Ivan A., D'Alessio, Paul A., Rangan, Pooja, Agarwal, Sumit K., Tinta, Nicole C., Martinez, Brandon K., Ziadat, Delia S., Yerondopoulos, Melanie J., Kobic, Emir, Kane-Gill, Sandra L.
Zdroj:	Journal of Critical Care; 20210101, Issue: Preprints
Abstrakt:	The risk of acute kidney injury (AKI) associated with concomitant vancomycin and piperacillin/tazobactam in the intensive care unit (ICU) remains controversial. The purpose was to compare the AKI incidence associated with concomitant vancomycin and piperacillin/tazobactam compared to either cefepime or meropenem with vancomycin in the ICU.
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect